A detailed history of Btr Capital Management Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Btr Capital Management Inc holds 6,570 shares of NVO stock, worth $756,338. This represents 0.1% of its overall portfolio holdings.

Number of Shares
6,570
Previous 6,570 -0.0%
Holding current value
$756,338
Previous $732,000 10.52%
% of portfolio
0.1%
Previous 0.11%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Jan 12, 2021

SELL
$63.89 - $73.8 $79,862 - $92,250
-1,250 Reduced 15.98%
6,570 $459,000
Q3 2020

Oct 15, 2020

SELL
$63.69 - $70.22 $31,845 - $35,110
-500 Reduced 6.01%
7,820 $543,000
Q4 2018

Jan 23, 2019

SELL
$41.54 - $47.25 $16,242 - $18,474
-391 Reduced 4.49%
8,320 $383,000
Q3 2018

Oct 04, 2018

BUY
$46.76 - $51.24 $18,283 - $20,034
391 Added 4.7%
8,711 $411,000
Q3 2017

Oct 27, 2017

BUY
$41.15 - $49.22 $342,368 - $409,510
8,320
8,320 $401,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $260B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Btr Capital Management Inc Portfolio

Follow Btr Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Btr Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Btr Capital Management Inc with notifications on news.